Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia.

The International journal on drug policy - 1 Feb 2018

Kikvidze Tamar, Luhmann Niklas, Avril Elisabeth, Butsashvili Maia, Labartkava Konstantine, Etienne Aurélie, Le Pluart Diane, Inaridze Ina, Gamezardashvili Ana, Kharshiladze David, Bouscaillou Julie

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Georgia (Republic)
Share to Health Services Accessibility

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Peer Group

Share to Pilot Projects

Share to Substance Abuse, Intravenous

Source

Identifiers

PMID: 29227878
DOI: 10.1016/j.drugpo.2017.11.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia.PMID 29227878Read ↗

Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort studySemantic proximity Read ↗

Hepatitis C among people who inject drugs in Tbilisi, Georgia: an urgent need for prevention and treatment.Semantic proximity Read ↗

Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: An evaluation of programmatic and treatment outcomes.Semantic proximity Read ↗

Computer-Based Alcohol Reduction Intervention for Alcohol-Using HIV/HCV Co-Infected Russian Women in Clinical Care: Study Protocol for a Randomized Controlled TrialSemantic proximity Read ↗

Interim impact evaluation of the hepatitis C virus elimination program in GeorgiaSemantic proximity Read ↗

Outcomes of Pharmacist-Led Treatment of Hepatitis C in the Virginia Department of Corrections.Semantic proximity Read ↗

Barriers of linkage to HCV viremia testing among people who inject drugs in GeorgiaSemantic proximity Read ↗

A systematic review of community based hepatitis C treatment.Semantic proximity Read ↗

Prevalence and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: a cross sectional studySemantic proximity Read ↗

Delivery of treatment for hepatitis C virus infection in the primary care setting.Semantic proximity Read ↗

Harm Reduction Service Utilization Among People Who Inject Drugs in Tajikistan: Prevalence and Precipitating FactorsSemantic proximity Read ↗

A novel model of care; Telemedicine and peer support for HCV care among HIV infected people who inject drugs in remote Myanmar: A retrospective studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.